Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children.

Suppr

超能文献

作者信息

Borofsky L G, Louis S, Kutt H, Roginsky M

出版信息

J Pediatr. 1972 Nov;81(5):995-1002. doi: 10.1016/s0022-3476(72)80561-4.

DOI:10.1016/s0022-3476(72)80561-4

PMID:5086732

Abstract

摘要

相似文献

Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children.

J Pediatr. 1972 Nov;81(5):995-1002. doi: 10.1016/s0022-3476(72)80561-4.

Iatrogenic diphenylhydantoin (dilantin) intoxication.

Tex Med. 1975 Feb;71(2):49-52.

Single daily dose of diphenylhydantoin in children.

J Pediatr. 1973 Sep;83(3):479-83. doi: 10.1016/s0022-3476(73)80281-1.

Diphenylhydantoin in children. Pharmacology and efficacy.

Neurology. 1973 Sep;23(9):967-72. doi: 10.1212/wnl.23.9.967.

[Difference of serum diphenylhydantoin levels between cases taking diphenylhydantoin alone and cases taking multiple anti-convulsants in various age groups (author's transl)].

No To Shinkei. 1979 Jun;31(6):561-8.

Oral phenytoin in infancy: dose requirement, absorption, and elimination.

Pediatr Pharmacol (New York). 1983;3(3-4):229-36.

Plasma diphenylhydantoin levels in Australian children.

Aust N Z J Med. 1974 Oct;4(5):456-61. doi: 10.1111/j.1445-5994.1974.tb03217.x.

Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient.

J Pediatr. 1980 Mar;96(3 Pt 1):479-84. doi: 10.1016/s0022-3476(80)80705-0.

Chronic and severe phenobarbital intoxication in a child treated with primidone and diphenylhydantoin.

J Pediatr. 1973 Sep;83(3):484-9. doi: 10.1016/s0022-3476(73)80282-3.

Plasma glucose and insulin responses to oral glucose with chronic diphenylhydantoin therapy.

Pediatrics. 1973 Jun;51(6):1091-3.

引用本文的文献

Loperamide versus diphenoxylate in diarrhea of infants and children.

Indian J Pediatr. 1980 Jul-Aug;47(387):303-6. doi: 10.1007/BF02831323.

Drug level monitoring in paediatric practice.

Arch Dis Child. 1980 Feb;55(2):89-98. doi: 10.1136/adc.55.2.89.

Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.

Clin Pharmacokinet. 1983 Nov-Dec;8(6):545-9. doi: 10.2165/00003088-198308060-00006.

Therapeutic drug monitoring.

Indian J Pediatr. 1986 Mar-Apr;53(2):149-62. doi: 10.1007/BF02748503.

Disposition of anticonvulsants in childhood.

Clin Pharmacokinet. 1989;17 Suppl 1:89-104. doi: 10.2165/00003088-198900171-00007.

Therapeutic drug monitoring of phenytoin. Rationale and current status.

Clin Pharmacokinet. 1990 Nov;19(5):341-58. doi: 10.2165/00003088-199019050-00001.

Therapeutic drug monitoring of anticonvulsants. State of the art.

Clin Pharmacokinet. 1990 Apr;18(4):318-28. doi: 10.2165/00003088-199018040-00004.

The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Proc R Soc Med. 1975 Feb;68(2):102-4. doi: 10.1177/003591577506800218.

Clinical pharmacokinetics in infants and children.

Clin Pharmacokinet. 1976;1(1):2-24. doi: 10.2165/00003088-197601010-00002.

The clinical pharmacokinetics of phenytoin.

J Pharmacokinet Biopharm. 1977 Dec;5(6):579-96. doi: 10.1007/BF01059685.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children.

J Pediatr. 1972 Nov;81(5):995-1002. doi: 10.1016/s0022-3476(72)80561-4.

Iatrogenic diphenylhydantoin (dilantin) intoxication.

Tex Med. 1975 Feb;71(2):49-52.

Single daily dose of diphenylhydantoin in children.

J Pediatr. 1973 Sep;83(3):479-83. doi: 10.1016/s0022-3476(73)80281-1.

Diphenylhydantoin in children. Pharmacology and efficacy.

Neurology. 1973 Sep;23(9):967-72. doi: 10.1212/wnl.23.9.967.

[Difference of serum diphenylhydantoin levels between cases taking diphenylhydantoin alone and cases taking multiple anti-convulsants in various age groups (author's transl)].

No To Shinkei. 1979 Jun;31(6):561-8.

Oral phenytoin in infancy: dose requirement, absorption, and elimination.

Pediatr Pharmacol (New York). 1983;3(3-4):229-36.

Plasma diphenylhydantoin levels in Australian children.

Aust N Z J Med. 1974 Oct;4(5):456-61. doi: 10.1111/j.1445-5994.1974.tb03217.x.

Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient.

J Pediatr. 1980 Mar;96(3 Pt 1):479-84. doi: 10.1016/s0022-3476(80)80705-0.

Chronic and severe phenobarbital intoxication in a child treated with primidone and diphenylhydantoin.

J Pediatr. 1973 Sep;83(3):484-9. doi: 10.1016/s0022-3476(73)80282-3.

Plasma glucose and insulin responses to oral glucose with chronic diphenylhydantoin therapy.

Pediatrics. 1973 Jun;51(6):1091-3.

引用本文的文献

Loperamide versus diphenoxylate in diarrhea of infants and children.

Indian J Pediatr. 1980 Jul-Aug;47(387):303-6. doi: 10.1007/BF02831323.

Drug level monitoring in paediatric practice.

Arch Dis Child. 1980 Feb;55(2):89-98. doi: 10.1136/adc.55.2.89.

Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.

Clin Pharmacokinet. 1983 Nov-Dec;8(6):545-9. doi: 10.2165/00003088-198308060-00006.

Therapeutic drug monitoring.

Indian J Pediatr. 1986 Mar-Apr;53(2):149-62. doi: 10.1007/BF02748503.

Disposition of anticonvulsants in childhood.

Clin Pharmacokinet. 1989;17 Suppl 1:89-104. doi: 10.2165/00003088-198900171-00007.

Therapeutic drug monitoring of phenytoin. Rationale and current status.

Clin Pharmacokinet. 1990 Nov;19(5):341-58. doi: 10.2165/00003088-199019050-00001.

Therapeutic drug monitoring of anticonvulsants. State of the art.

Clin Pharmacokinet. 1990 Apr;18(4):318-28. doi: 10.2165/00003088-199018040-00004.

The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Proc R Soc Med. 1975 Feb;68(2):102-4. doi: 10.1177/003591577506800218.

Clinical pharmacokinetics in infants and children.

Clin Pharmacokinet. 1976;1(1):2-24. doi: 10.2165/00003088-197601010-00002.

The clinical pharmacokinetics of phenytoin.

J Pharmacokinet Biopharm. 1977 Dec;5(6):579-96. doi: 10.1007/BF01059685.